Effectiveness of biologic switching in a real-life, Belgian severe asthma cohort

IF 3.1 4区医学 Q3 IMMUNOLOGY

Immunity, Inflammation and Disease Pub Date : 2024-10-08 DOI:10.1002/iid3.70023

Lucie Lafarge, Charles Pilette, Céline Bugli, Antoine Froidure

引用次数: 0

Abstract

In this observational study, we show that switching biologics in severe asthma results in a high proportion of controlled patients.

Abstract Image

查看原文本刊更多论文

在一个真实的比利时重症哮喘队列中，生物制剂转换的效果。

在这项观察性研究中，我们发现重症哮喘患者更换生物制剂后，病情得到控制的患者比例很高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunity, Inflammation and Disease Medicine-Immunology and Allergy

CiteScore

3.60

自引率

0.00%

发文量

146

审稿时长

8 weeks

期刊介绍： Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including: • cellular and molecular immunology • clinical immunology • allergy • immunochemistry • immunogenetics • immune signalling • immune development • imaging • mathematical modelling • autoimmunity • transplantation immunology • cancer immunology